3Alexandrakis MG, Moschandrea JA, Koulacheri SA, et al. Discrimination Between Malignant and Nonmalignant Ascites Using Serum and Ascitic Fluid Proteins in a Multivariate Analysis Model [ J]. Dig Dis Sci,2000,45(3):500.
4Giusti G. Methods of enzymatic analysis. Bergmeger H U New York: Acad. Presss Inc, 1974 : 1092.
5程明．CEA—EIA试药盒的研制及临床应用．北京：卫生部北京生物制品研究所，1981：25．
6Piras MA. Adenosine deaminase activity in pleural effusion aid to differential diagnosis. Br Med J, 1978,2 : 1751.
6T. Nobuhisa,Y. Naomoto,T. Ohkawa,M. Takaoka,R. Ono,T. Murata,M. Gunduz,Y. Shirakawa,T. Yamatsuji,M. Haisa,J. Matsuoka,H. Tsujigiwa,H. Nagatsuka,M. Nakajima,N. Tanaka.Heparanase expression correlates with malignant potential in human colon cancer[J]Journal of Cancer Research and Clinical Oncology,2005(4).
7Kuralag F,Tokog Z,Comlekci A.Diagnostic usefulness of tumormarker levels in pleural effusions of malignant and benign originClinica Chimica Acta,2000.
9Schofield K,,D′Aquila T,Rimm DL.E2cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimensDiagnostic Cytopathology,2000.
10Rana SV,Babu SG,Koccchar R.Usefulness of ascitie fluid eholes-terol as a marker for malignant ascitesMedical Science Monitor,2005.
